Clinical Trials Logo

Arthralgia clinical trials

View clinical trials related to Arthralgia.

Filter by:

NCT ID: NCT04535596 Completed - Resistance Training Clinical Trials

Blood Flow Restriction Exercises and Conservative Exercises in Knee Osteoarthritis

Start date: September 1, 2020
Phase: N/A
Study type: Interventional

Knee osteoarthritis (OA) is a rheumatic disease that causes serious cartilage damage in the knee joint. Moderate physical activity can slow cartilage degeneration in moderate OA stages. Remarkable weakness and atrophy of the quadriceps and hamstrings is a common problem in patients with chronic osteoarthritis, but in arthritis, it may be difficult to achieve strength gains due to the pain caused by heavy load-resistant exercises. Exercising with these high loads may not be possible or may injure painful arthritic knees. For this reason, lately, blood flow restriction exercises have been directed to achieve the same gain by exercising with lower loads by restricting the blood flow with a cuff. We aimed to limit the blood flow in osteoarthritic knees and to provide strength gain and pain reduction provided by conventional exercises given routinely. Our hypothesis in this study is that exercises that blood flow restriction exercises will reduce pain and increase strength as well as conventional exercises.

NCT ID: NCT04520958 Completed - Pain Clinical Trials

Preoperative Psychosocial Support for Postoperative Recovery and Health: Mechanistic Substudy

Start date: October 29, 2019
Phase: N/A
Study type: Interventional

This was a single site, three-arm, parallel group randomized clinical trial that compared the effect of three preoperative psychosocial interventions on knee and hip replacement patients' preoperative pain intensity and postoperative pain intensity, pain unpleasantness, and opioid use.

NCT ID: NCT04511832 Completed - Breast Cancer Clinical Trials

Comparative Effectiveness of Acupuncture and Nonsteroidal Anti-inflammatory Drugs for the Management of Aromatase Inhibitor Induced Arthralgia Among Breast Cancer Survivors

Start date: March 28, 2018
Phase: N/A
Study type: Interventional

Hormone therapy is used to treat women with hormone receptor-positive breast cancer and aromatase inhibitor (AI) is administered after menopause. AI therapy has been proven to be effective in improving the disease-free survival rate, decreasing the recurrence rates and a lower incidence of contralateral breast cancer. However, arthralgia frequently reported as an important adverse event of AI therapy and sometimes resulted in noncompliance with AI therapy. The prevalence of AI induced arthralgia rates ranged from 20 to 74%. Inadequately managed AI induced arthralgia remains a major unmet need in oncology practice in breast cancer survivors. The goal of this project is to conduct a crossover designed pragmatic clinical trial to evaluate the effectiveness of acupuncture versus NSAID (Diclofenac) for the management of aromatase inhibitor induced arthralgia. The third group was set to use non-steroidal analgesics plus acupuncture to evaluate the effectiveness of joint pain.

NCT ID: NCT04506411 Completed - Joint Pain Clinical Trials

Turmeric Efficacy for Mobility and Joint Function

T-MOTION
Start date: September 24, 2020
Phase: N/A
Study type: Interventional

The objective of the study is to test the capacity of a 12-weeks Turmipure GOLD® supplementation to reduce joint discomfort.

NCT ID: NCT04500210 Completed - Quality of Life Clinical Trials

Comparative Study of Turmeric Extract in Patients With Arthrosis.

Start date: January 1, 2020
Phase: Phase 3
Study type: Interventional

The aim of this study is to test if an extract of Turmeric can alleviate symptoms of osteoarthritis in volunteers with osteoarthritis of the hip and or knee.

NCT ID: NCT04481711 Completed - Orthopedic Disorder Clinical Trials

Total Knee Arthroplasty and Clinical Findings

Start date: November 8, 2018
Phase: N/A
Study type: Interventional

Knee osteoarthritis is a common disease that causes pain and loss of function. Total Knee Arthroplasty (TKA) is a frequently used surgical method in the treatment of severe knee osteoarthritis. The aim of this study was to investigate the effect of TKA on IL-6, TNF-α and IL-1β cytokine levels, pain intensity at rest and walking, knee joint valgity angle,malaligment, functional status and knee joint position sense.

NCT ID: NCT04446988 Completed - Clinical trials for Sacro-Iliac Spondylosis

Ultrasound Versus Fluoroscopic Guided Sacroiliac Joint Injection In Patients With Chronic Sacroiliac Joint Pain

Start date: October 15, 2019
Phase: N/A
Study type: Interventional

Sacroiliac joint injection in sacroiliitis

NCT ID: NCT04408560 Completed - Clinical trials for Breast Cancer Female

Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer

ARHOMA2
Start date: September 13, 2018
Phase: N/A
Study type: Interventional

Interventional, randomised, prospective, monocentric study

NCT ID: NCT04215198 Completed - Clinical trials for Exercise-induced Joint Pain

NEM® + KD PUR® Fish Oil Versus Placebo in Exercised-induced Joint Pain, Stiffness, & Cartilage Turnover in Healthy Men & Women

Move3
Start date: September 20, 2018
Phase: N/A
Study type: Interventional

This study is intended to evaluate the effect of the dietary supplement combination of NEM® brand eggshell membrane + KD PUR® brand fish oil versus placebo in reducing exercise-induced joint pain, stiffness & cartilage turnover in healthy men & women. Half of the study participants will receive NEM + fish oil, once daily, orally while the other half of the study participants will receive placebo, once daily, orally while performing an exercise regimen every other day for two weeks.

NCT ID: NCT04161833 Completed - Breast Cancer Clinical Trials

Opera® for Aromatase Inhibitor-related Arthralgia Management (AIA)

AIA
Start date: November 1, 2018
Phase: N/A
Study type: Interventional

In this phase II, multicenter, self-controlled clinical trial, we will evaluate the safety and efficacy of OPERA® for treating anti-aromate inhibitors (AIs) induced arthralgia. The diagnosis of arthralgia will be based on the NCI-CTCAE v4.0 grade of ≥ 1 , A disorder characterized by a sensation of marked discomfort in a joint, mild pain (grade 1). Arthralgia will be assessed at the enrollment and every two months until the sixth month.